<?xml version="1.0" encoding="UTF-8"?>
<ref id="B56">
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Gaudinski</surname>
    <given-names>M. R.</given-names>
   </name>
   <name>
    <surname>Houser</surname>
    <given-names>K. V.</given-names>
   </name>
   <name>
    <surname>Morabito</surname>
    <given-names>K. M.</given-names>
   </name>
   <name>
    <surname>Hu</surname>
    <given-names>Z.</given-names>
   </name>
   <name>
    <surname>Yamshchikov</surname>
    <given-names>G.</given-names>
   </name>
   <name>
    <surname>Rothwell</surname>
    <given-names>R. S.</given-names>
   </name>
   <etal/>
  </person-group> (
  <year>2018</year>). 
  <article-title>Safety, tolerability, and immunogenicity of two Zika virus DNA vaccine candidates in healthy adults: randomised, open-label, phase 1 clinical trials.</article-title>
  <source>
   <italic>Lancet</italic>
  </source>
  <volume>391</volume>
  <fpage>552</fpage>â€“
  <lpage>562</lpage>. 
  <pub-id pub-id-type="doi">10.1016/S0140-6736(17)33105-7</pub-id>
  <?supplied-pmid 29217376?>
  <pub-id pub-id-type="pmid">29217376</pub-id>
 </mixed-citation>
</ref>
